Skip to main content
. 2020 Dec 17;23(3):362–369a. doi: 10.1093/europace/euaa298

Figure 2.

Figure 2

Time to primary endpoint (occurrence of persistent atrial fibrillation/tachycardia) by treatment group: (A) ITT patient cohorts, (B) PP patient cohorts, (C) as-treated patient cohorts, and (D) ITT patient cohorts using the 2017 expert consensus Heart Rhythm Society definition of persistent atrial fibrillation. Note adherence to 90-day (0.25 year) blanking period in all panels. AAD, antiarrhythmic drug therapy; AF, atrial fibrillation; AT, atrial tachycardia; ITT, intention-to-treat; PP, per-protocol; RF, radiofrequency.